Back

Liver fibrosis in heart failure patients is associated with adverse outcomes, signs of congestion, and ⍺v integrin-related processes: insights from BIOSTAT-CHF

31 August 2026 (09:40 - 09:50)
Organised by: Logo
Congress Presentation Part of: Multi-organ frailty: liver fibrosis, kidney, and left atrial remodelling Comorbidities ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Mark Zhi Kang Tow

Dundee (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Frailty redefines the prognostic value of multimorbidity in heart failure
Doctor V. Copeland (Ramat Gan, IL)
Abstract
Presentation thumbnail
Study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function (BalanceD-HF): background and design
Professor J. Teerlink (San Francisco, US)
Abstract
Presentation thumbnail
Performance of an artificial intelligence-based smartphone application to assess frailty in older patients with heart failure
Mr S. Tahara (Sapporo, JP)
Abstract
Presentation thumbnail
Metabolomic signature predicting ejection fraction recovery in recent-onset dilated cardiomyopathy
Doctor Y. Xie (CN)
Abstract
Presentation thumbnail
Left atrial remodeling and microstructural damage in the internal capsule in heart failure: a comparison based on left atrial maximum volume index stratification
Doctor C. Pan (Zhuhai, CN)
Abstract

Access the full session

Session thumbnail
Multi-organ frailty: liver fibrosis, kidney, and left atrial remodelling

The Event

Event poster

ESC Congress 2026

31 August 2026 09:40 CET
You may be interested in
thumbnail
Congress Presentation
Liver fibrosis and poor outcome in patients with heart failure: new insights from the BIOSTAT-CHF study
31 August 2025
thumbnail
Congress Presentation
Significant association between left ventricular diastolic dysfunction, left atrial performance and liver stiffness in patients with metabolic syndrome and non-alcoholic fatty liver disease
29 June 2021
thumbnail
Congress Presentation
Serum proteome profiling reflects the risk of pulmonary hypertension in chronic heart failure patients
1 July 2021
thumbnail
Congress Presentation
Hepatitis C-associated atrial and ventricular remodeling and poor ablation outcomes via persistent inflammation in atrial fibrillation patients without sustained virological response
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources